Drug Development Services: Dried Blood Spot (DBS)
BASi has emphasized the importance of reducing animal numbers and refining data. We are continuing this tradition as we move forward with utilizing Dried Blood Spot (DBS) technologies and have a number of initiatives that capture the advantages dried sample spots offer.
Dried Blood Spot sampling offers advantages for the collection, storage and shipping of blood samples for drug analysis. The small volumes utilized in DBS are a good fit for multiple small volume collections from animals such as mice and rats. Use of DBS technologies for this purpose make it possible to reduce the overall number of experimental animals required for development. However, this collection technique goes beyond early discovery and can be a low-stress sampling option for mice as well as man.
Bioanalytical DBS Services
- Collaborative efforts between our bioanalytical labs in the US and the UK have allowed us to successfully evaluate the bioanalysis of dried blood spots and have developed DBS analysis expertise at each of our three bioanalytical facilities.
- Our staff and programs are flexible to generate both the study design and timelines you need.
- We offer complementary services in preclinical development, toxicology, bioanalysis, and TK reporting.
Culex® Automated DBS Sampling
- BASi is the designer and manufacturer of theCulex® Family of instruments for automated blood sampling and has designed a solution to integrate DBS into the blood collection system.
- Culex® will collect accurate and reliable Dried Blood Spot samples at user-programmed time points for direct delivery onto DBS paper.
- Our unique sample collection card allows drawing of up to 32 DBS samples with 1-4 samples per time point and the ability to retain separate replicate samples.
- Culex® reduces human intervention during sample collection, resulting in reduced stress when compared to sampling manually.
The BASi Advantage
- Integration of DBS sampling on Culex® for small and large animal models complements our existing DBS bioanalytical capability.
- The combination of our in-house team of scientists and engineers ensures we will continue to make improvements to the collection and analysis of Dried Blood Spot samples.
- We provide our customers with DBS solutions that encompass the drug development process from discovery to clinical trials.
Related Articles
- The Culex® Automated In Vivo Sampling System: A Novel Technique for Dried Blood Spot (DBS) Collection in Preclinical Studies
Peter White, David Hopper, Robin Lane, Tyler McGraw, Bhavna Mistry, Amanda Plumb and Candace Rohde
- Validation of an LC-MS/MS Method for the Determination of Quetiapine, Norquetiapine and Quetiapine Sulphoxide in Human Whole Blood Using the Dried Blood Spot TechniqueNeil Doleman, Robin Lane
BASi, UK - Evaluation of the Dried Blood Spot Technique for the Quantification of Diltiazem in Human Blood
Neil Doleman, BASi, UK
Tidak ada komentar:
Posting Komentar